Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04151953 · ClinicalTrials.gov registry record
Myocardial Injury in Patients With Cardiac Implantable Electronic Devices Following Magnetic Resonance Imaging
A clinical trial, sponsored by Mayo Clinic.
- Completed
- Registry status
- 105
- Enrollment target
NCT04151953: Completed study, sponsored by Mayo Clinic.
NCT04151953 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 105 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04151953 has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 105 participants
- Enrollment target
Study Summary
Researchers are trying to determine if heart injury occurs in subjects with cardiac implantable electronic device (CIED), such as a pacemaker or implantable cardioverter defibrillator (ICD), who undergo a magnetic resonance imaging (MRI).
Primary Outcome
Changes in high sensitivity cardiac troponin T (hs-cTnT) or troponin I (hs-cTnI) assay
Interventions
- DIAGNOSTIC_TEST Blood sample collection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 105 participants |
| Start Date | 2019-10-08 |
| Est. Completion | 2021-12-01 |
What the finished NCT04151953 record still lists
NCT04151953 is an observational study that tracks outcomes without assigning an intervention. The registered 105 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Blood sample collection is the first listed.
NCT04151953 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04151953 about?
NCT04151953 is a clinical study titled "Myocardial Injury in Patients With Cardiac Implantable Electronic Devices Following Magnetic Resonance Imaging". Researchers are trying to determine if heart injury occurs in subjects with cardiac implantable electronic device (CIED), such as a pacemaker or implantable cardioverter defibrillator (ICD), who undergo a magnetic resonance imaging (MRI).
What is the current status of trial NCT04151953?
This trial is currently completed. The enrollment target is 105 participants. The study started on 2019-10-08. Estimated completion is 2021-12-01.
What interventions are being tested in trial NCT04151953?
The interventions under investigation include: Blood sample collection (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04151953?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03372317 · 105 participants
Tau PET in Imaging and Cognition: Healthy Adults From 55-90
- NCT04253964 · 105 participants · Phase 2
Pilot Study of Performance Status 2 vs. Performance Status 0-1 Non-small Cell Lung Cancer Patients Treated With Chemo/Immunotherapy
- NCT04742452 · 105 participants · NA
Comparison of Partial Rotator Cuff Repair vs. Superior Capsular Reconstruction for Irreparable Rotator Cuff Tears
- NCT04875429 · 105 participants · NA
Zenith® Fenestrated+ Clinical Study
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI